Literature DB >> 25833879

Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes.

Tatjana S Potpara1, Deirdre A Lane2, Gregory Y H Lip3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833879     DOI: 10.1093/europace/euv041

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  3 in total

1.  Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases.

Authors:  Il Young Cho
Journal:  Ther Clin Risk Manag       Date:  2019-10-08       Impact factor: 2.423

Review 2.  Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

Authors:  Hans-Christoph Diener; James Aisenberg; Jack Ansell; Dan Atar; Günter Breithardt; John Eikelboom; Michael D Ezekowitz; Christopher B Granger; Jonathan L Halperin; Stefan H Hohnloser; Elaine M Hylek; Paulus Kirchhof; Deirdre A Lane; Freek W A Verheugt; Roland Veltkamp; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2017-03-21       Impact factor: 29.983

3.  Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy.

Authors:  Judith J Stephenson; Mayura U Shinde; Winghan Jacqueline Kwong; An-Chen Fu; Hiangkiat Tan; William S Weintraub
Journal:  Patient Prefer Adherence       Date:  2018-01-12       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.